胃内肉毒素注射用于减肥:当前趋势,缺陷和未来的前景
Erfan Arabpour1, Hadi Golmoradi1, Parya Mozafari Komesh Tape1
1Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Clinical endoscopy
|December 25, 2024
概括
毒素A (BTA) 注射用于减肥是一种新的内镜减肥手术. 然而,不一致的研究方法阻碍了对BTA的清晰理解.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 减肥医学 减肥医学
背景情况:
- 胃内肉毒素A (BTA) 注射是肥胖管理的新兴内镜减肥手术.
- 尽管最初的人体试验已经过去了20多年,但关于胃内BTA的安全性,疗效和标准化协议的重大争论仍在继续.
- 现有的文献在研究方法上呈现出相当多的异质性,包括BTA剂量,注射部位,技术,术后饮食指南和随访期的变化.
研究的目的:
- 审查当前的证据和毒素A用于体重管理的最新应用.
- 批判性地分析支持BTA在肥胖的治疗用途的临床证据.
主要方法:
- 对关于肥胖的胃内肉毒素A注射的现有文献进行系统审查.
- 分析研究的临床结果和BTA用于减肥的治疗应用.
主要成果:
- 目前关于胃内BTA减肥的研究缺乏方法的一致性.
- 在BTA剂量,注射参数和随访协议的差异使得有效性和安全性数据的解释变得复杂.
- 关于BTA管理的最佳程序指南的明确共识尚未建立.
结论:
- 采用一致的结果措施和标准化方法的进一步研究至关重要.
- 标准化研究是必要的,以最终评估毒素A在有效的体重管理中的潜力.
- 澄清BTA在减肥干预中的作用需要严格,统一的临床试验.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
653
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
653
Skeletal Muscle Relaxants: Therapeutic Uses
463
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
463
Glucagon-like Receptor Agonists
297
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
297
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
75
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
75
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Enteral Nutrition I: Orogastric and Nasogastric Feeding
194
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
194


